%0 Journal Article
%T Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice
%A Yosuke Hanai
%A Ken Shimono
%A Hiroaki Oka
%A Yoshinobu Baba
%A Kunio Yamazaki
%A Gary K Beauchamp
%J Cancer Cell International
%D 2012
%I BioMed Central
%R 10.1186/1475-2867-12-7
%X Several VOCs were found at significantly increased or decreased concentrations in the headspace of the A549 cell culture medium as compared with the culture medium of two normal lung cell lines. We also analyzed the urine of mice implanted with A549 cells and several VOCs were also found to be significantly increased or decreased relative to urine obtained from control mice. It was also revealed that seven VOCs were found at increased concentrations in both sample types. These compounds were found to be dimethyl succinate, 2-pentanone, phenol, 2-methylpyrazine, 2-hexanone, 2-butanone and acetophenone.Both sample types produce distinct biomarker profiles, and VOCs have potential to distinguish between true- and false-positive screens for lung cancer.A 2008 report issued by the WHO [1], estimates that about 18% of all of cancer deaths can be attributed to lung cancer. Annually, lung cancer accounts for about 1.3 million deaths worldwide. For this reason, the development of a novel diagnostic test, which can facilitate the early detection of lung cancer, has the ability to vastly reduce lung cancer mortality rates. Although many studies report the utility of diagnostic imaging such as X-ray and CT scan, these modalities are both expensive and susceptible to false positive and false negative results.The ability to combine imaging techniques with other methodologies such as biomarkers is a strategy with the potential to enhance the detection of lung cancer [2-4]. Although various biomarkers from blood, saliva and urine have been detected, including proteins, tumor antigens, anti-tumor antibodies, cell type-specific peptides, metabolic products and epigenetic phenomena such as hyper-methylated DNA, RNA, and the expression of specific genes [5], to date none of these biomarkers has had the adequate sensitivity, specificity and reproducibility to be considered for use clinically.The analysis of exhaled breath for endogenous volatile organic compounds (VOCs) is one possible
%K Lung cancer
%K VOCs
%K GC-TOF MS
%K Cell medium
%K Urine
%K Tumor-bearing mice
%U http://www.cancerci.com/content/12/1/7